FDA recall D-0104-2021
Jubilant Cadista Pharmaceuticals, Inc. · Class II · drug
Product
clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD NDC 59746-711-30
Reason for recall
Failed Tablet/Capsule Specification
Distribution
Product was distributed nationwide.
Key facts
- Status
- Terminated
- Initiation date
- 2020-11-06
- Report date
- 2020-12-02
- Termination date
- 2022-03-23
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Salisbury, MD, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0104-2021